Table 3.
Examples of kidney-specific interventions that prevent or attenuate salt-sensitive increases in blood pressure (BP)
| Transplantation of kidney from normotensive human donors normalizes BP in | |
| Patients with apparent mineralocorticoid excess | Kattab et al78 |
| Patients with Liddle’s syndrome | Botero-Velez et al79 |
| Patients with essential hypertension | Curtis et al,80 |
| Transplantation of kidneys from normotensive donor rats reduces/normalizes BP in | |
| Dahl salt-sensitive rats | Dahl et al70 |
| Prague Hypertensive rats | Heller et al72 |
| Milan Hypertensive rats | Bianchi et al71 |
| Spontaneously hypertensive rats | Kawabe et al73 |
| Collecting duct-specific renin deletion attenuates AngII hypertension | |
| Ramkumar et al84 | |
| Distal convoluted tubule-specific deletion of NCC transporter reverses hypertension caused by WNK4 mutations (pseudohypoaldosteronism type II) | |
| Lalioti et al85 | |
| Kidney-specific deletion of TNF-α attenuates AngII hypertension | Zhang et al86 |
| Kidney-specific deletion of AT1 receptors blocks chronic AngII hypertension | |
| Crowley et al62 | |
| Proximal tubule-specific deletion of AT1 receptors attenuates AngII hypertension | |
| Gurley et al63 | |
| Renal denervation lowers blood pressure in | |
| Obese hypertensive humans | DiBona and Esler87 |
| Obese hypertensive experimental animals | Henegar et al88 |